BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Clinical trial NCT02160041 · TERMINATED
Trial details
- NCT number
- NCT02160041
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-24
- Primary completion
- 2018-04-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.